Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 780.41 million. The enterprise value is 594.85 million.
| Market Cap | 780.41M |
| Enterprise Value | 594.85M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.43% |
| Float | 476.14M |
Valuation Ratios
The trailing PE ratio is 10.58.
| PE Ratio | 10.58 |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| PB Ratio | 1.57 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | 10.31 |
| P/OCF Ratio | 8.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.83, with an EV/FCF ratio of 7.86.
| EV / Earnings | 7.32 |
| EV / Sales | 1.93 |
| EV / EBITDA | 5.83 |
| EV / EBIT | 7.02 |
| EV / FCF | 7.86 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.02 |
| Quick Ratio | 3.43 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.24% and return on invested capital (ROIC) is 11.23%.
| Return on Equity (ROE) | 17.24% |
| Return on Assets (ROA) | 9.50% |
| Return on Invested Capital (ROIC) | 11.23% |
| Return on Capital Employed (ROCE) | 17.02% |
| Revenue Per Employee | 845,248 |
| Profits Per Employee | 222,511 |
| Employee Count | 373 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 0.93 |
Taxes
In the past 12 months, Biofarm has paid 11.04 million in taxes.
| Income Tax | 11.04M |
| Effective Tax Rate | 11.96% |
Stock Price Statistics
The stock price has increased by +5.00% in the last 52 weeks. The beta is 0.31, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +5.00% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 38.06 |
| Average Volume (20 Days) | 52,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 308.52 million and earned 81.22 million in profits. Earnings per share was 0.07.
| Revenue | 308.52M |
| Gross Profit | 259.50M |
| Operating Income | 84.77M |
| Pretax Income | 92.25M |
| Net Income | 81.22M |
| EBITDA | 102.01M |
| EBIT | 84.77M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 186.58 million in cash and 1.01 million in debt, giving a net cash position of 185.56 million or 0.19 per share.
| Cash & Cash Equivalents | 186.58M |
| Total Debt | 1.01M |
| Net Cash | 185.56M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 496.53M |
| Book Value Per Share | 0.50 |
| Working Capital | 274.00M |
Cash Flow
In the last 12 months, operating cash flow was 90.90 million and capital expenditures -15.23 million, giving a free cash flow of 75.68 million.
| Operating Cash Flow | 90.90M |
| Capital Expenditures | -15.23M |
| Free Cash Flow | 75.68M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 84.11%, with operating and profit margins of 27.48% and 26.32%.
| Gross Margin | 84.11% |
| Operating Margin | 27.48% |
| Pretax Margin | 29.90% |
| Profit Margin | 26.32% |
| EBITDA Margin | 33.07% |
| EBIT Margin | 27.48% |
| FCF Margin | 24.53% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.91%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.91% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 35.97% |
| Buyback Yield | -0.41% |
| Shareholder Yield | 3.48% |
| Earnings Yield | 10.41% |
| FCF Yield | 9.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 7.19 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.19 |
| Piotroski F-Score | 7 |